Andrew McKibben | executive |
Christopher Peetz | executive |
Peter Radovich | executive |
Joanne M. Quan | executive |
Eric Bjerkholt | executive |
Dae Gon Ha | analyst |
Mani Foroohar | analyst |
Jessica Fye | analyst |
David Lebowitz | analyst |
Steven Seedhouse | analyst |
Jonathan Wolleben | analyst |
Wing Yip | analyst |
Good afternoon, everyone, and welcome to the Mirum Pharmaceuticals reports second quarter 2024 financial results and provides business update. My name is Carla, and I will be coordinating your call today. [Operator Instructions] I will now hand you over to Andrew McKibben, Vice President of Investor Relations and Finance, to begin. Andrew, please go ahead.
Thanks, Carla, and good afternoon, everyone.